Pharmacodynamics of Caplacizumab in Healthy Volunteers and Phase 2/3 Trial Patients with Immune-mediated Thrombotic Thrombocytopenic Purpura

Thrombosis and Haemostasis · Published 2026-07-15 · DOI 10.1055/a-2905-2494

Free full text

Authors (10)

Paul Coppo, Marie Ann Scully, Javier de la Rubia, Flora Peyvandi, Spero R. Cataland, Paul Knoebl, Katerina Pavenski, Umer Khan, Ana Paula Marques, Sriya Gunawardena

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Coppo, P., Scully, M., Rubia, J., et al. (2026). Pharmacodynamics of Caplacizumab in Healthy Volunteers and Phase 2/3 Trial Patients with Immune-mediated Thrombotic Thrombocytopenic Purpura. Thrombosis and Haemostasis. https://doi.org/10.1055/a-2905-2494

Related articles

• A Conotoxin-Derived Peptide Selectively Inhibits PAR-1 Mediated Thrombosis and Neutrophil Extracellular Traps Formation Without Affecting Hemostasis · Thrombosis and Haemostasis · 2026 · Same journal
• Room-Temperature Stability of Argatroban, Danaparoid, and Fondaparinux in Plasma: A Multicenter Study · Thrombosis and Haemostasis · 2026 · Same journal
• Prasugrel vs. Ticagrelor: Can TUXEDO-2 Settle the Debate? · Thrombosis and Haemostasis · 2026 · Same journal
• Impact of Atrial Fibrillation on Thrombotic Complications in Myeloproliferative Neoplasms Real-World Analysis · Thrombosis and Haemostasis · 2026 · Same journal
• Beyond the Average Effect: Identifying the Trauma Patients Who Benefit Most from Tranexamic Acid · Thrombosis and Haemostasis · 2026 · Same journal
• Mapping Laboratory Phenotype–Genotype in Von Willebrand Disease: A Belgian National Survey · Thrombosis and Haemostasis · 2026 · Same journal
• Sex-Dependent Platelet Inhibition with Prasugrel and Ticagrelor after Percutaneous Coronary Intervention in Acute Coronary Syndromes · Thrombosis and Haemostasis · 2026 · Same journal
• Bruton Tyrosine Kinase as Therapeutic Target in Cardiovascular Diseases—Executive Summary · Thrombosis and Haemostasis · 2026 · Same journal
• Synergistic Thrombolysis–Antiplatelet Therapy of Engineered tPA Variant citPA5 and Tirofiban in a Mouse Stroke Model · Thrombosis and Haemostasis · 2026 · Same journal
• Association of Longitudinal Fibrinogen Trajectories with Mortality in Sepsis: A Group-based Trajectory Analysis · Thrombosis and Haemostasis · 2026 · Same journal